A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: Baseline characteristics and dosimetry results

Gillian C. Barnett(University of Cambridge), Jennifer Wilkinson(Cambridge University Hospitals NHS Foundation Trust), A.M. Moody(Cambridge University Hospitals NHS Foundation Trust), Charles B. Wilson(Cambridge University Hospitals NHS Foundation Trust), Ravi Sharma(University of Aberdeen), S. Kläger(Great Ormond Street Hospital), Andrew Hoole(Cambridge University Hospitals NHS Foundation Trust), N. Twyman(Cambridge University Hospitals NHS Foundation Trust), N.G. Burnet(University of Cambridge), Charlotte E. Coles(Cambridge University Hospitals NHS Foundation Trust)
Radiotherapy and Oncology
April 18, 2009
10.1016/j.radonc.2009.03.003
Cited by 114

Abstract

Related Papers

Prescribing, recording, and reporting photon beam therapy
Icru|Medical Entomology and Zoology|1993|2k
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials
|The Lancet|2000|1.2k
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials
M Clarke, R Collins, C Davies et al.|The Lancet|2000|825
A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis
Jean‐Philippe Pignol, Ivo A. Olivotto, Eileen Rakovitch et al.|Journal of Clinical Oncology|2008|754
Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy
Ellen M. Donovan, Natalie Bleakley, Erica Denholm et al.|Radiotherapy and Oncology|2007|477